Related Experiment Video
Updated: Sep 7, 2025

07:18
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
7.0K
A rare case of cutaneous interdigitating dendritic cell sarcoma
Leandra Doan1, Riana D Sanyal2, David S Cassarino2
1Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.
Journal of Cutaneous Pathology
|June 16, 2022
Summary
Interdigitating dendritic cell sarcoma (IDCS) is an aggressive tumor. This case highlights diagnostic challenges, as cutaneous IDCS can mimic melanoma, emphasizing the need for careful histopathologic and immunohistochemical evaluation.
Area of Science:
- Dermatopathology
- Oncology
- Immunohistochemistry
Background:
- Interdigitating dendritic cell sarcoma (IDCS) is a rare and aggressive neoplasm of dendritic cells.
- Primary cutaneous IDCS is exceptionally uncommon, with fewer than 10 reported cases.
- Distinguishing IDCS from other spindle cell tumors, such as melanoma, can be challenging based on H&E morphology alone.
Observation:
- A case of a man with a cutaneous IDCS initially misdiagnosed as melanoma is presented.
- Histopathology revealed atypical dermal lymphohistiocytic infiltrate with nests at the dermal-epidermal junction.
- Immunohistochemistry showed positivity for S100, fascin, and lysozyme, with negativity for CD1a, langerin, CD21, CD23, and SOX10.
Findings:
- The immunohistochemical profile confirmed the diagnosis of IDCS.
- Re-examination of a prior biopsy specimen also identified it as cutaneous IDCS.
- PET scan indicated no evidence of metastases, supporting a primary cutaneous origin.
Implications:
- This case underscores the diagnostic difficulties in differentiating cutaneous IDCS from melanoma.
- Accurate diagnosis relies on a combination of histopathology and specific immunohistochemical markers.
- Understanding these overlapping features is crucial for appropriate patient management and treatment of this rare cutaneous malignancy.

